Simple blood test can predict which breast cancer treatment will work best, study findsSimple blood test can predict which breast cancer treatment will work best, study finds
Exclusive: DNA test would mean patients could be offered most effective treatment first, boosting their chances of beating the diseaseScientists have developed a simple DNA blood test that can predict how well patients with breast cancer will respond to treatment.More than 2 million people globally are diagnosed each year with the disease, which is the world’s most prevalent cancer. Although treatments have improved in recent decades, it is not easy to know which ones will work best for which patients. Continue reading…
Physician-Journalist Shines Light on Measles Upsurge and New GLP-1 StudyPhysician-Journalist Shines Light on Measles Upsurge and New GLP-1 Study
KFF Health News editor-at-large for public health Céline Gounder discussed an increase in measles cases in the U.S. on CBS News’ CBS Mornings on Jan. 15. Gounder also discussed a new study on GLP-1 weight loss drugs on CBS News’ CBS News 24/7 and CBS Mornings on Jan. 8. Click here to watch Gounder discuss Read More
Doctors Arrested After Newborn Deaths; Nurse’s Fake Ozempic Charge; Surgeon ArrestedDoctors Arrested After Newborn Deaths; Nurse’s Fake Ozempic Charge; Surgeon Arrested
(MedPage Today) — Top doctors at a Russian hospital in Siberia have been arrested after nine newborns died there this month. (CBS News) A nurse in Chicago was charged for giving patients fake semaglutide (Ozempic, Wegovy). (CBS News) Michael… (MedPage Today) — Top doctors at a Russian hospital in Siberia have been arrested after Read More
Finding new cell markers to track the most aggressive breast cancer in bloodFinding new cell markers to track the most aggressive breast cancer in blood
Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC is also more likely to metastasize, or travel through the bloodstream to spread to other organs, which causes most of breast cancer-related deaths each year.
FDA moves to remove suicide warnings from GLP-1 weight loss drugsFDA moves to remove suicide warnings from GLP-1 weight loss drugs
Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal thoughts, and they have asked drugmakers to remove those warnings from medication labels. Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal thoughts, and they have Read More
Air Pollution and Cardiac Remodeling and Function in Patients With Breast CancerAir Pollution and Cardiac Remodeling and Function in Patients With Breast Cancer
This cohort study assesses associations between exposure to air pollutants and changes in cardiac structure, function, and remodeling in patients with breast cancer treated with potentially cardiotoxic therapies.
Metabolic bariatric surgery tied to improvement in psoriasis outcomesMetabolic bariatric surgery tied to improvement in psoriasis outcomes
Metabolic bariatric surgery (MBS) is associated with improved outcomes in patients with psoriasis, according to a review published online Jan. 12 in BMC Surgery.
I’m an RD—Here Are 4 Steps I Recommend Before Starting a GLP-1I’m an RD—Here Are 4 Steps I Recommend Before Starting a GLP-1
These will help you build a supportive foundation for the body. These will help you build a supportive foundation for the body.
GLP-1 Drugs Tied to Mortality Reduction in Colon Cancer Patients With ObesityGLP-1 Drugs Tied to Mortality Reduction in Colon Cancer Patients With Obesity
(MedPage Today) — SAN FRANCISCO — Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and fewer serious non-cancer complications, a propensity-matched cohort study showed. The retrospective… (MedPage Today) — SAN FRANCISCO — Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality Read More
ctDNA levels after neoadjuvant therapy may predict breast cancer recurrence better than pathologic complete responsectDNA levels after neoadjuvant therapy may predict breast cancer recurrence better than pathologic complete response
The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer after they received neoadjuvant treatment and surgery predicted worse outcomes than in those patients without ctDNA, even in patients with a pathologic complete response (pCR), according to a study published in Cancer Research Communications.